A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles

被引:226
作者
Cohen-Sela, Einat [1 ]
Chorny, Michael [1 ]
Koroukhov, Nickolay [1 ]
Danenberg, Haim D. [2 ]
Golomb, Gershon [1 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel
[2] Hadassah Hebrew Univ Hosp, Dept Cardiol, IL-9112 Jerusalem, Israel
基金
以色列科学基金会;
关键词
Nanoparticles formulation; Hydrophilic; Double emulsion; PLGA; Macrophages restenosis; BIODEGRADABLE NANOSPHERES; NEOINTIMAL FORMATION; INTIMAL HYPERPLASIA; DELIVERY-SYSTEMS; POLYLACTIC ACID; DRUG; NANOPRECIPITATION; RELEASE; STERILIZATION; RABBITS;
D O I
10.1016/j.jconrel.2008.09.073
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The commonly utilized techniques for encapsulating hydrophilic molecules in NP suffer from low encapsulation efficiency because of the drug rapid partitioning to the external aqueous phase. We hypothesized that combining the double emulsion system with a partially water-soluble organic solvent, could result in better encapsulation yield of hydrophilic molecules in nano-sized NP, and the utilization of both biocompatible surfactants and solvents. As a model drug we used alendronate, a hydrophilic low MW bisphosphonate. The new NP preparation technique, double emulsion solvent diffusion (DES-D), resulted in improved formulation characteristics including smaller size. lower size distribution, higher encapsulation yield, and more biocompatible ingredients in comparison to classical methods. The utilization of partially water-miscible organic solvent (ethyl acetate) enabled rapid diffusion through the aqueous phase forming smaller NP. In addition, the formulated alendronate NP exhibited Profound inhibition of raw 264 macrophages, depletion of rabbit's circulating monocytes, and inhibition of restenosis in the rat model. It is concluded that the new technique is advantageous in terms of smaller size, lower size distribution, higher encapsulation yield, and more biocompatible ingredients, with unaltered bioactivity. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 30 条
  • [1] Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers
    Athanasiou, KA
    Niederauer, GG
    Agrawal, CM
    [J]. BIOMATERIALS, 1996, 17 (02) : 93 - 102
  • [2] Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method
    Barichello, JM
    Morishita, M
    Takayama, K
    Nagai, T
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) : 471 - 476
  • [3] Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content
    Budhian, Avinash
    Siegel, Steven J.
    Winey, Karen I.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (02) : 367 - 375
  • [4] Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics
    Chorny, M
    Fishbein, I
    Danenberg, HD
    Golomb, G
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) : 389 - 400
  • [5] Nanospheres of a bisphosphonate attenuate intimal hyperplasia
    Cohen-Sela, Einat
    Dangoor, David
    Epstein, Hila
    Gati, Irith
    Danenberg, Haim D.
    Golomb, Gershon
    Gao, Jianchuan
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2006, 6 (9-10) : 3226 - 3234
  • [6] Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis
    Cohen-Sela, Einat
    Rosenzweig, Ohad
    Gao, Jianchuan
    Epstein, Hila
    Gati, Irith
    Reich, Reuven
    Danenberg, Haim D.
    Golomb, Gershon
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 113 (01) : 23 - 30
  • [7] Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits
    Danenberg, HD
    Golomb, G
    Groothuis, A
    Gao, JC
    Epstein, H
    Swaminathan, RV
    Seifert, P
    Edelman, ER
    [J]. CIRCULATION, 2003, 108 (22) : 2798 - 2804
  • [8] Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits
    Danenberg, HD
    Fishbein, I
    Gao, JC
    Mönkkönen, J
    Reich, R
    Gati, I
    Moerman, E
    Golomb, G
    [J]. CIRCULATION, 2002, 106 (05) : 599 - 605
  • [9] Fessi J. P. D. H., 1992, US Patent, Patent No. [5,118,528, 5118528]
  • [10] Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats
    Fishbein, I
    Waltenberger, J
    Banai, S
    Rabinovich, L
    Chorny, M
    Levitzki, A
    Gazit, A
    Huber, R
    Mayr, U
    Gertz, SD
    Colomb, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) : 667 - 676